MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

Balance Sheets Overview

Current Ratio
56.92%
Quick Ratio
56.92%
Cash Ratio
45.21%
Debt to Asset Ratio
140.65%
Unit: Dollar
Assets Breakdown
    • Cash and cash equivalents
    • Prepaid expenses
    • Prepaid expenses and other asset...
    • Others
Liabilities Breakdown
    • Accumulated deficit
    • Additional paid-in capital
    • Accounts payable
    • Others
Balance Sheets
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Cash and cash equivalents
5,596,254
21,660,496
26,711,969
26,198,652
Prepaid expenses and other assets
1,448,939
1,225,381
1,542,116
1,694,258
Total current assets
7,045,193
22,885,877
28,254,085
27,892,910
Prepaid expenses
1,548,580
1,548,580
1,996,300
6,554,064
Property and equipment
-
-
295,911
-
Less accumulated depreciation
-
-
175,727
-
Property and equipment, net
176,612
114,725
120,184
125,643
Financing lease right-to-use assets
36,828
113,844
123,514
133,184
Total assets
8,807,213
24,663,026
30,494,083
34,705,801
Accounts payable
6,393,967
3,650,352
3,574,448
5,180,928
Accrued expenses
1,629,313
1,258,817
742,227
2,104,390
Current portion of debt
4,322,500
5,206,574
5,130,372
6,000,000
Financing lease obligation-short term
31,696
30,982
36,167
44,142
Total current liabilities
12,377,476
10,146,725
9,483,214
13,329,460
Debt, net of debt discount
0
10,605,985
11,733,350
11,889,314
Financing lease obligation-long term
9,476
17,673
25,686
33,517
Total liabilities
12,386,952
20,770,383
21,242,250
25,252,291
Common stock, 0.00033 par value, 150,000,000 shares authorized at june 30, 2026 and december 31, 2025, respectively 55,921,806 and 54,878,233 issued and outstanding at june 30, 2026 and december 31, 2025, respectively
18,455
18,420
18,111
15,744
Additional paid-in capital
230,107,941
227,829,783
225,840,226
218,481,351
Accumulated deficit
-233,706,135
-223,955,560
-216,606,504
-209,043,585
Total stockholders' equity
-3,579,739
3,892,643
9,251,833
9,453,510
Total liabilities and stockholders' equity
8,807,213
24,663,026
30,494,083
34,705,801
Unit: Dollar. Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Cash and cashequivalents$5,596,254 (-82.44%↓ Y/Y)Prepaid expenses andother assets$1,448,939 (-18.35%↓ Y/Y)Total current assets$7,045,193 (-79.06%↓ Y/Y)Prepaid expenses$1,548,580 (-76.37%↓ Y/Y)Property and equipment,net$176,612 (34.71%↑ Y/Y)Financing leaseright-to-use assets$36,828 (-74.22%↓ Y/Y)Total assets$8,807,213 (-78.24%↓ Y/Y)Accumulated deficit-$233,706,135 (-16.83%↓ Y/Y)Total liabilities andstockholders' equity$8,807,213 (-78.24%↓ Y/Y)Total stockholders'equity-$3,579,739 (-122.43%↓ Y/Y)Additional paid-in capital$230,107,941 (6.54%↑ Y/Y)Common stock, 0.00033par value,...$18,455 (19.92%↑ Y/Y)Total liabilities$12,386,952 (-49.47%↓ Y/Y)Total currentliabilities$12,377,476 (7.34%↑ Y/Y)Financing leaseobligation-long term$9,476 (-76.98%↓ Y/Y)Accounts payable$6,393,967 (42.17%↑ Y/Y)Current portion of debt$4,322,500 (-21.41%↓ Y/Y)Accrued expenses$1,629,313 (9.93%↑ Y/Y)Financing leaseobligation-short term$31,696 (-38.97%↓ Y/Y)

PDS Biotechnology Corp (PDSB)

PDS Biotechnology Corp (PDSB)